[COVID-19 AND AUTOIMMUNE DISEASES].


Journal

Harefuah
ISSN: 0017-7768
Titre abrégé: Harefuah
Pays: Israel
ID NLM: 0034351

Informations de publication

Date de publication:
Feb 2021
Historique:
entrez: 24 3 2021
pubmed: 25 3 2021
medline: 27 3 2021
Statut: ppublish

Résumé

The immune system could be affected by a mixture of factors. It is customary to classify factors that affect the immune system into three main groups: hereditary, environmental and hormonal factors. When those factors deviate from their normal physiological effect, in the genetically pre-dispositioned, an autoimmune disease may erupt and a lymphoma may develop as a result. Viruses are a significant part of the environmental factors that affect the immune system. Recent evidence demonstrates the ability of the COVID-19 virus to induce hyper-stimulation of the immune system, thus leading to the formation of autoantibodies in patients. This effect of the COVID-19 virus is caused by two main courses of action: firstly, its ability to induce hyper-stimulation of the immune system; secondly, its molecular similarity to humans. Numerous records demonstrate the tendency of severely ill COVID-19 patients to develop multiple autoantibodies known to be found in common autoimmune diseases, such as antinuclear antibodies, antiphospholipid antibodies, and many more. Additionally, many case reports have been published on COVID-19 infected patients who developed autoimmune diseases. It is extremely important to recognize the autoimmune effects of the COVID-19 virus when dealing with the ongoing pandemic.

Identifiants

pubmed: 33760404

Substances chimiques

Autoantibodies 0

Types de publication

Journal Article

Langues

heb

Sous-ensembles de citation

IM

Pagination

62-67

Auteurs

Arad Dotan (A)

MD MPH studies, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Yehuda Shoenfeld (Y)

Sheba Medical Center, Tel Hashomer, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH